IRIS Accounts Production v25.1.4.42 10360271 director 1.10.23 30.9.24 30.9.24 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh103602712023-09-30103602712024-09-30103602712023-10-012024-09-30103602712022-09-30103602712022-10-012023-09-30103602712023-09-3010360271ns15:EnglandWales2023-10-012024-09-3010360271ns14:PoundSterling2023-10-012024-09-3010360271ns10:Director12023-10-012024-09-3010360271ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3010360271ns10:SmallEntities2023-10-012024-09-3010360271ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3010360271ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3010360271ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3010360271ns10:FullAccounts2023-10-012024-09-3010360271ns10:OrdinaryShareClass12023-10-012024-09-3010360271ns5:CurrentFinancialInstruments2024-09-3010360271ns5:CurrentFinancialInstruments2023-09-3010360271ns5:ShareCapital2024-09-3010360271ns5:ShareCapital2023-09-3010360271ns5:RetainedEarningsAccumulatedLosses2024-09-3010360271ns5:RetainedEarningsAccumulatedLosses2023-09-3010360271ns10:RegisteredOffice2023-10-012024-09-3010360271ns5:FurnitureFittings2023-10-012024-09-3010360271ns5:ComputerEquipment2023-10-012024-09-3010360271ns5:FurnitureFittings2023-09-3010360271ns5:ComputerEquipment2023-09-3010360271ns5:FurnitureFittings2024-09-3010360271ns5:ComputerEquipment2024-09-3010360271ns5:FurnitureFittings2023-09-3010360271ns5:ComputerEquipment2023-09-3010360271ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3010360271ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-3010360271ns5:AcceleratedTaxDepreciationDeferredTax2024-09-3010360271ns5:AcceleratedTaxDepreciationDeferredTax2023-09-3010360271ns5:TaxLossesCarry-forwardsDeferredTax2024-09-3010360271ns5:TaxLossesCarry-forwardsDeferredTax2023-09-3010360271ns5:DeferredTaxation2023-09-3010360271ns5:DeferredTaxation2023-10-012024-09-3010360271ns5:DeferredTaxation2024-09-3010360271ns10:OrdinaryShareClass12024-09-30
REGISTERED NUMBER: 10360271 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED

30 SEPTEMBER 2024

FOR

PARSONS MEDICAL LTD

PARSONS MEDICAL LTD (REGISTERED NUMBER: 10360271)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024










Page

Balance Sheet 1

Notes to the Financial Statements 3


PARSONS MEDICAL LTD (REGISTERED NUMBER: 10360271)

BALANCE SHEET
30 SEPTEMBER 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 5 721 1,286

CURRENT ASSETS
Debtors 6 9,185 2,184
Cash at bank 10,295 7,488
19,480 9,672
CREDITORS
Amounts falling due within one year 7 14,557 10,765
NET CURRENT ASSETS/(LIABILITIES) 4,923 (1,093 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

5,644

193

PROVISIONS FOR LIABILITIES 8 137 9
NET ASSETS 5,507 184

CAPITAL AND RESERVES
Called up share capital 9 100 100
Retained earnings 5,407 84
SHAREHOLDERS' FUNDS 5,507 184

PARSONS MEDICAL LTD (REGISTERED NUMBER: 10360271)

BALANCE SHEET - continued
30 SEPTEMBER 2024


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the director and authorised for issue on 26 June 2025 and were signed by:





Dr I Parsons - Director


PARSONS MEDICAL LTD (REGISTERED NUMBER: 10360271)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024


1. STATUTORY INFORMATION

Parsons Medical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 10360271

Registered office: 4 Broadoaks Crescent
West Byfleet
Surrey
KT14 6RP

The presentation currency of the financial statements is the Pound Sterling (£).


2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Turnover
The turnover shown in the profit and loss account represents amounts receivable for services provided and goods sold during the year.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Equipment - 20% on reducing balance
Computer equipment - 25% on cost

All fixed assets are initially recorded at cost.


PARSONS MEDICAL LTD (REGISTERED NUMBER: 10360271)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


3. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability.

Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

PARSONS MEDICAL LTD (REGISTERED NUMBER: 10360271)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


5. TANGIBLE FIXED ASSETS
Computer
Equipment equipment Totals
£    £    £   
COST
At 1 October 2023
and 30 September 2024 327 4,710 5,037
DEPRECIATION
At 1 October 2023 65 3,686 3,751
Charge for year 53 512 565
At 30 September 2024 118 4,198 4,316
NET BOOK VALUE
At 30 September 2024 209 512 721
At 30 September 2023 262 1,024 1,286

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 8,965 2,140
Corporation tax recoverable - 44
Prepayments and accrued income 220 -
9,185 2,184

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 210 -
Corporation tax 1,311 -
Director's current account 11,398 9,210
Accruals and deferred income 1,638 1,555
14,557 10,765

PARSONS MEDICAL LTD (REGISTERED NUMBER: 10360271)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


8. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax
Accelerated capital allowances 137 244
Tax losses carried forward - (235 )
137 9

Deferred
tax
£   
Balance at 1 October 2023 9
Provided during year 128
Balance at 30 September 2024 137

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
100 Ordinary £1 100 100